Related Experiment Video
Updated: Mar 1, 2026
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Transcatheter Occlusion of the Left Atrial Appendage
1Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Insights
Left atrial appendage closure is a new treatment for patients with nonvalvular atrial fibrillation. This procedure can prevent blood clots and reduce the risk of stroke, offering an alternative to long-term anticoagulation.
Area of Science:
- Cardiology
- Medical Devices
- Interventional Procedures
Background:
- The left atrial appendage is a common source of thrombi in nonvalvular atrial fibrillation.
- Thrombi formation in the left atrial appendage can lead to embolic stroke.
- Lifelong anticoagulation is the standard therapy but carries bleeding risks.
Purpose of the Study:
- To discuss transcatheter left atrial appendage occlusion/exclusion as a novel therapeutic approach.
- To evaluate left atrial appendage closure as an alternative to anticoagulation.
- To review the clinical data supporting left atrial appendage closure.
Main Methods:
- Transcatheter procedures for left atrial appendage occlusion/exclusion.
- Evaluation of patient suitability for the procedure.
- Review of procedural techniques and outcomes.
Main Results:
- Left atrial appendage occlusion/exclusion is a viable alternative to anticoagulation.
- The procedure shows potential for preventing embolic stroke.
- Clinical data supports the efficacy and safety of left atrial appendage closure.
Conclusions:
- Transcatheter left atrial appendage occlusion/exclusion offers a promising alternative to lifelong anticoagulation.
- This approach can significantly reduce the risk of stroke in patients with nonvalvular atrial fibrillation.
- Further clinical data and procedural refinement are ongoing.
Abstract:
The left atrial appendage is a primary source of thrombi in patients with nonvalvular atrial fibrillation. Transcatheter left atrial appendage occlusion/exclusion is a novel technology with the potential as an alternative approach for lifelong anticoagulation to prevent potential catastrophic embolic stroke. This article discusses important evaluation, procedural steps, and the clinical data for left atrial appendage closure.
